The primary endpoint is to measure the change in liver stiffness measurement performed by transient elastography from Baseline to Week 52
Bayer reported the highest market capitalization growth of 23.1% during Q1 2023
Galvus has the potential to contribute significantly to Cipla’s portfolio in the diabetes care continuum space with reported sales of Rs. 268 crore
Pre-filled pens containing a combination of insulin glargine 100 Units/mL and lixisenatide for once-daily dosing
Canagliflozin and Metformin Hydrochloride Tablets had annual sales of US $49.4 million in the United States
The drug will be manufactured at the group’s formulation manufacturing facility at Moraiya
The supplemental New Drug Application is based on results from the landmark EMPA-KIDNEY phase III trial
He has published more than 100 research papers in several prestigious national and international journals
Empagliflozin is a novel sodium glucose co-transporter-2 (SGLT-2) inhibitor, which is useful for improving glycaemic control in adults with type-2 diabetes mellitus.
The patent also covers the efficacy of the herbal composition in the management of metabolic syndrome disorders
Subscribe To Our Newsletter & Stay Updated
